Medtronic received information that approximately three to four months post implant of this mechanical valve, the patient started experiencing symptoms.Testing confirmed the valve was not functioning as expected.The valve was explanted and replaced.Upon explant, the surgeon noted that one of the leaflets of the mechanical valve was immobile.No additional adverse patient effects were reported. .
|
Medtronic received additional information that approximately three to four months post implant of this 19mm mechanical valve, the patient presented with symptoms of difficulty breathing and malaise.Echocardiogram identified an immobile leaflet.During the replacement procedure when the patient's chest was opened, the surgeon tested the leaflet motion of the 19mm valve and it was functioning as expected.Upon closing the patient's chest, the leaflet became immobile again, and the valve was ultimately explanted and replaced with a 21mm mechanical valve of the same model.No additional adverse patient effects were reported. medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|